Literature DB >> 23644494

Insights into mitochondrial quality control pathways and Parkinson's disease.

Susann Lehmann1, L Miguel Martins.   

Abstract

The brain uses more energy than any other human organ, accounting for 20 % of the body's total demand. Mitochondria are energy-converting organelles with a pivotal role in meeting the energetic needs of the human brain. Therefore, the decline of these cellular powerhouses can have a negative impact on the function and plasticity of neurons and is believed to have a prominent role in ageing and in the occurrence of several neurological disorders, such as Parkinson's disease (PD). As a consequence of their physiological roles, mitochondria are subjected to high levels of stress and have therefore developed several stress-protective mitochondrial quality control mechanisms that ensure the optimal activity of their molecular machinery. Here, we review some of the most recent advances in our understanding of the regulation of mitochondrial stress pathways with particular emphasis on how defective mitochondrial quality control might contribute to PD.

Entities:  

Mesh:

Year:  2013        PMID: 23644494     DOI: 10.1007/s00109-013-1044-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  50 in total

Review 1.  Quality control of mitochondria: protection against neurodegeneration and ageing.

Authors:  Takashi Tatsuta; Thomas Langer
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

2.  Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.

Authors:  Javier Simón-Sánchez; Andrew B Singleton
Journal:  Hum Mol Genet       Date:  2008-03-25       Impact factor: 6.150

3.  Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response.

Authors:  Cristina Benedetti; Cole M Haynes; Yun Yang; Heather P Harding; David Ron
Journal:  Genetics       Date:  2006-07-02       Impact factor: 4.562

4.  Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.

Authors:  L Miguel Martins; Benjamin E Turk; Victoria Cowling; Annabel Borg; Emily T Jarrell; Lewis C Cantley; Julian Downward
Journal:  J Biol Chem       Date:  2003-09-25       Impact factor: 5.157

5.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

6.  Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease.

Authors:  Veerle Bogaerts; Karen Nuytemans; Joke Reumers; Philippe Pals; Sebastiaan Engelborghs; Barbara Pickut; Ellen Corsmit; Karin Peeters; Joost Schymkowitz; Peter Paul De Deyn; Patrick Cras; Frederic Rousseau; Jessie Theuns; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

7.  Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.

Authors:  N Moisoi; K Klupsch; V Fedele; P East; S Sharma; A Renton; H Plun-Favreau; R E Edwards; P Teismann; M D Esposti; A D Morrison; N W Wood; J Downward; L M Martins
Journal:  Cell Death Differ       Date:  2008-11-21       Impact factor: 15.828

8.  In situ localization of mitochondrial DNA replication in intact mammalian cells.

Authors:  A F Davis; D A Clayton
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

9.  OPA1 requires mitofusin 1 to promote mitochondrial fusion.

Authors:  Sara Cipolat; Olga Martins de Brito; Barbara Dal Zilio; Luca Scorrano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-27       Impact factor: 11.205

10.  PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.

Authors:  Julia W Pridgeon; James A Olzmann; Lih-Shen Chin; Lian Li
Journal:  PLoS Biol       Date:  2007-06-19       Impact factor: 8.029

View more
  9 in total

1.  Understanding neuronal dysfunction and loss in neurodegenerative disease.

Authors:  Flaviano Giorgini
Journal:  J Mol Med (Berl)       Date:  2013-06       Impact factor: 4.599

2.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

3.  Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.

Authors:  Shinichi Amano; Deborah Kegelmeyer; S Lee Hong
Journal:  Front Syst Neurosci       Date:  2015-01-06

4.  Fusion or Fission: The Destiny of Mitochondria In Traumatic Brain Injury of Different Severities.

Authors:  Valentina Di Pietro; Giacomo Lazzarino; Angela Maria Amorini; Stefano Signoretti; Lisa J Hill; Edoardo Porto; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

5.  Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease.

Authors:  Susann Lehmann; Samantha H Y Loh; L Miguel Martins
Journal:  Biol Open       Date:  2017-02-15       Impact factor: 2.422

Review 6.  Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.

Authors:  Joel R Frandsen; Prabagaran Narayanasamy
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

7.  Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle Enzymes Are Sensitive Targets of Traumatic Brain Injury Induced Metabolic Derangement.

Authors:  Giacomo Lazzarino; Angela Maria Amorini; Stefano Signoretti; Giuseppe Musumeci; Giuseppe Lazzarino; Giuseppe Caruso; Francesco Saverio Pastore; Valentina Di Pietro; Barbara Tavazzi; Antonio Belli
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

8.  Haemodynamic-directed cardiopulmonary resuscitation promotes mitochondrial fusion and preservation of mitochondrial mass after successful resuscitation in a pediatric porcine model.

Authors:  Kumaran Senthil; Ryan W Morgan; Marco M Hefti; Michael Karlsson; Andrew J Lautz; Constantine D Mavroudis; Tiffany Ko; Vinay M Nadkarni; Johannes Ehinger; Robert A Berg; Robert M Sutton; Francis X McGowan; Todd J Kilbaugh
Journal:  Resusc Plus       Date:  2021-04-29

9.  Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.

Authors:  S Lehmann; A C Costa; I Celardo; S H Y Loh; L M Martins
Journal:  Cell Death Dis       Date:  2016-03-31       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.